Utility of cardiac bioenzymes in predicting cardiovascular outcomes in SARS-CoV-2

The relationship between coronavirus disease-19 (COVID-19) and cardiovascular diseases has been an important issue. Therefore, cardiac biomarkers and cardiac imaging have an important place in the diagnostic phase. It is important to know the relationship of biomarkers in COVID-19 so that we can und...

Descripción completa

Detalles Bibliográficos
Autores principales: Gulmez, Ali Osman, Aydin, Sonay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2023
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10075052/
https://www.ncbi.nlm.nih.gov/pubmed/37033145
http://dx.doi.org/10.5501/wjv.v12.i2.132
_version_ 1785019841823899648
author Gulmez, Ali Osman
Aydin, Sonay
author_facet Gulmez, Ali Osman
Aydin, Sonay
author_sort Gulmez, Ali Osman
collection PubMed
description The relationship between coronavirus disease-19 (COVID-19) and cardiovascular diseases has been an important issue. Therefore, cardiac biomarkers and cardiac imaging have an important place in the diagnostic phase. It is important to know the relationship of biomarkers in COVID-19 so that we can understand the diagnosis of the disease, the predicted course and results after diagnosis.
format Online
Article
Text
id pubmed-10075052
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Baishideng Publishing Group Inc
record_format MEDLINE/PubMed
spelling pubmed-100750522023-04-06 Utility of cardiac bioenzymes in predicting cardiovascular outcomes in SARS-CoV-2 Gulmez, Ali Osman Aydin, Sonay World J Virol Letter to the Editor The relationship between coronavirus disease-19 (COVID-19) and cardiovascular diseases has been an important issue. Therefore, cardiac biomarkers and cardiac imaging have an important place in the diagnostic phase. It is important to know the relationship of biomarkers in COVID-19 so that we can understand the diagnosis of the disease, the predicted course and results after diagnosis. Baishideng Publishing Group Inc 2023-03-25 2023-03-25 /pmc/articles/PMC10075052/ /pubmed/37033145 http://dx.doi.org/10.5501/wjv.v12.i2.132 Text en ©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. https://creativecommons.org/licenses/by-nc/4.0/This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial.
spellingShingle Letter to the Editor
Gulmez, Ali Osman
Aydin, Sonay
Utility of cardiac bioenzymes in predicting cardiovascular outcomes in SARS-CoV-2
title Utility of cardiac bioenzymes in predicting cardiovascular outcomes in SARS-CoV-2
title_full Utility of cardiac bioenzymes in predicting cardiovascular outcomes in SARS-CoV-2
title_fullStr Utility of cardiac bioenzymes in predicting cardiovascular outcomes in SARS-CoV-2
title_full_unstemmed Utility of cardiac bioenzymes in predicting cardiovascular outcomes in SARS-CoV-2
title_short Utility of cardiac bioenzymes in predicting cardiovascular outcomes in SARS-CoV-2
title_sort utility of cardiac bioenzymes in predicting cardiovascular outcomes in sars-cov-2
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10075052/
https://www.ncbi.nlm.nih.gov/pubmed/37033145
http://dx.doi.org/10.5501/wjv.v12.i2.132
work_keys_str_mv AT gulmezaliosman utilityofcardiacbioenzymesinpredictingcardiovascularoutcomesinsarscov2
AT aydinsonay utilityofcardiacbioenzymesinpredictingcardiovascularoutcomesinsarscov2

Ejemplares similares